Urine testing is a simple and non-invasive way to screen for the presence of a number of diseases and conditions. Learn more below.
This test is used for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae. Laboratory findings demonstrating evidence of communicable disease must be reported to the Bureau of Disease Intervention of the Indiana State Department of Health. Reports may also be given to the local health officer.
Test Description: Testing for Chlamydia trachomatis and Neisseria gonorrhoeae is typically done at the same time because the symptoms are similar. The nucleic acid amplification that is used with the urine test, amplifies the DNA present in the urine to determine whether the sexually transmitted disease is present.
The patient should not have urinated for at least one hour prior to having the test completed.
This test is used to detect possible drug use.
Test Description: This test searches for traces of amphetamines, barbiturates, benzodiazepines, cocaine metabolite, opiates, phencyclidine, propoxyphene, and THC metabolite. Recommended for
monitoring whether drugs are present in the system.
This panel is useful in the evaluation of conditions such as urinary tract infection, dehydration, and kidney stones.
Test description: This test includes a macroscopic exam of: color, turbidity, specific gravity, pH, protein screen, glucose screen, ketones, bilirubin, blood, nitrite, and leukocyte esterase. It also includes a microscopic exam of: white blood cells (WBC), red blood cells (RBC), casts, crystals, epithelial cells, bacteria, and yeast.
This test is used to confirm or rule out pregnancy.
Test description: Human chorionic gonadotropin (hCG) is a two-chain glycoprotein hormone (MW approx. 37,000) normally found in blood and urine only during pregnancy. It is secreted by placental tissue, beginning with the primitive trophoblast, almost from the time of implantation, and serves to support the corpus luteum during the early weeks of pregnancy.
According to literature, circulating hCG typically reaches levels of approximately 2,000 mIU/mL one month after conception. A peak level on the order of 100,000 mIU/mL is attained in the third month, after which a gradual decline sets in. Following delivery, the hCG level normally undergoes rapid descent, reaching non-pregnant concentrations some two weeks later. Ectopic pregnancies and pregnancies terminating in spontaneous abortion tend to have lower than normal circulation hCG levels, while somewhat higher levels are often seen in multiple pregnancies.